NELIX
Price
$67.69
Change
+$0.09 (+0.13%)
Updated
Dec 3 closing price
Net Assets
152.35M
REMIX
Price
$14.63
Change
+$0.07 (+0.48%)
Updated
Dec 3 closing price
Net Assets
728.63M
Interact to see
Advertisement

NELIX vs REMIX

Header iconNELIX vs REMIX Comparison
Open Charts NELIX vs REMIXBanner chart's image
Nuveen Equity Long/Short I
Price$67.69
Change+$0.09 (+0.13%)
VolumeN/A
Net Assets152.35M
Standpoint Multi-Asset Investor
Price$14.63
Change+$0.07 (+0.48%)
VolumeN/A
Net Assets728.63M
NELIX vs REMIX Comparison Chart in %
View a ticker or compare two or three
VS
NELIX vs. REMIX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NELIX is a Buy and REMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
REMIX has more cash in the bank: 729M vs. NELIX (152M). REMIX pays higher dividends than NELIX: REMIX (5.38) vs NELIX (0.77). NELIX was incepted earlier than REMIX: NELIX (17 years) vs REMIX (6 years). NELIX (2.12) is less costly to investors than REMIX (1.64). REMIX has a lower initial minimum investment than NELIX: REMIX (2500) vs NELIX (100000). NELIX annual gain was more profitable for investors over the last year : 5.28 vs. REMIX (0.73). NELIX return over 5 years is better than : 70.10 vs. REMIX (46.37).
NELIXREMIXNELIX / REMIX
Total Expense Ratio1.931.51128%
Annual Report Gross Expense Ratio2.121.64129%
Fund Existence17 years6 years-
Gain YTD11.2702.665423%
Front LoadN/AN/A-
Min. Initial Investment10000025004,000%
Min. Initial Investment IRAN/AN/A-
Net Assets152M729M21%
Annual Yield % from dividends0.775.3814%
Returns for 1 year5.280.73726%
Returns for 3 years44.8315.54288%
Returns for 5 years70.1046.37151%
Returns for 10 years102.75N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BUFDX34.68N/A
N/A
Buffalo Growth & Income
RYWUX89.60N/A
N/A
Rydex Emerging Markets 2X Strategy C
MXEOX11.74N/A
N/A
Empower Emerging Markets Equity Inv
AVLVX16.00N/A
N/A
Avantis U.S. Large Cap Value Inst
JBAWX32.68N/A
N/A
JHancock Balanced R6